NEWS & MEDIA

Stay up to date with our latest news and upcoming events.

In the News

ivWatch Inks Distribution Deal with Terumo September 29, 2017 ivWatch has recently signed a licensing and distribution agreement with Terumo to improve patient safety, according to a Sept. 21 press release. Terumo will become the exclusive distributor of the ivWatch...

read more

In the News

ivWatch Enters Into Licensing and Distribution Agreement With Terumo to Help Improve Patient Safety September 21, 2017 ivWatch, LLC, the market leader for continuous IV infiltration and extravasation detection technology, today announced that Terumo Corporation, one...

read more

In the News

Monitoring devices for IVs August 29, 2017 ivWatch LLC, which offers continuous monitoring devices for the early detection of peripheral IV infiltrations, has been awarded an Innovative Technology contract from Vizient, Inc. The device can help in early detection of...

read more

In the News

ivWatch ISO 13485 certification opens the door for international distribution By Sandra J. Pennecke Aug 28, 2017, 5:00 PM EST ivWatch, LLC has achieved a certification that will allow it to reach even...

read more

In the News

IV therapy device company recognized By Michele Canty Aug 25, 2017, 7:00 PM ET ivWatch LLC received its ISO 13485 certification by the International Organization for Standardization, the Hampton company announced in August. The medical device company focuses on...

read more

For media inquiries, please contact:

Amara Betoney
ivWatch Manager, Public Relations
Direct: 757-224-2606
Office: 855-489-2824 ext. 7007
Mobile:757-660-4949
amara.betoney@ivwatch.com

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest